Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Prepaid Assets (2019 - 2026)

Enliven Therapeutics has reported Prepaid Assets over the past 8 years, most recently at $10.7 million for Q1 2026.

  • Quarterly results put Prepaid Assets at $10.7 million for Q1 2026, up 125.4% from a year ago — trailing twelve months through Mar 2026 was $10.7 million (up 125.4% YoY), and the annual figure for FY2025 was $12.3 million, up 164.56%.
  • Prepaid Assets reached $10.7 million in Q1 2026 per ELVN's latest filing, down from $12.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $12.3 million in Q4 2025 and bottomed at $2.2 million in Q4 2022.
  • Median Prepaid Assets over the past 5 years was $5.1 million (2025), compared with a mean of $5.5 million.
  • Peak annual rise in Prepaid Assets hit 164.56% in 2025, while the deepest fall reached 28.28% in 2025.
  • Over 5 years, Prepaid Assets stood at $2.2 million in 2022, then surged by 33.02% to $2.9 million in 2023, then soared by 57.1% to $4.6 million in 2024, then surged by 164.56% to $12.3 million in 2025, then dropped by 12.41% to $10.7 million in 2026.
  • Business Quant data shows Prepaid Assets for ELVN at $10.7 million in Q1 2026, $12.3 million in Q4 2025, and $5.1 million in Q3 2025.